To investigate the impact of AR expression on the outcome of breast cancer treated with neoadjuvant chemotherapy, we analyzed the correlation between AR status and DFS in molecular subtypes of neoadjuvant breast cancer. The gene discussed is AR; the disease is breast cancer.